BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, March 16, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 14, 1998
View Archived Issues
Company Profile: Gryphon Sciences
Read More
Xoma: Q3 1998 highlights
Read More
Schering-Plough files NDA for next-generation corticosteroid
Read More
Virological and pharmacokinetic profile presented for structurally novel NNRTIs from DuPont
Read More
Alliance formed by Penwest and Chiroscience to combine isomer and drug delivery technologies
Read More
OraVax and Pasteur Merieux Connaught codevelop dengue fever vaccine
Read More
Philippines is the first market for lamivudine as anti-HBV agent
Read More
Shire to apply drug delivery technologies to Searle product
Read More
Novel GM-CSF-containing fusion toxin shows excellent antileukemia activity in mouse model
Read More
SomatoKine provides significant benefit in severe burn trial
Read More
La Jolla presents promising primate data on new xenotransplantation Toleragen candidate
Read More
MAb-tyrosine kinase inhibitor immunoconjugate induces disease remission in ALL patients
Read More
Dendritic cell therapies based on Dendreon technology focus of Dendreon-Kirin partnership
Read More
FDA approves expanded indication for CytoGam
Read More
New U.S. patent provides Cortex exclusivity for Ampakine compounds
Read More
Novel anticoagulant serpin described by U.S. academics
Read More
AEterna signs CTA with NCI and reports lung cancer pivotal trial protocol details
Read More
E.U.-wide marketing approval granted for Muse
Read More
Japanese ACAT inhibitor is safe and effective in several animal species
Read More
New NK1 antagonists with excellent in vitro and in vivo profile designed at Merck & Co.
Read More
P&G submits NDA for antiarrhythmic drug azimilide
Read More
Clinical testing of inhaled antihistamine appears warranted in asthma patients
Read More
Highly potent anti-HIV betulin derivative acts at a late stage in the viral life cycle
Read More
Raloxifene evaluated for one year in established postmenopausal osteoporosis
Read More
Celgene acquires EntreMed rights to thalidomide
Read More
